How do you pay?

How to pay the least

Ask for the cash price

Hemgenix

Hemgenix is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Hemgenix’s cash price, and one or two other pharmacies too.
  2. Hemgenix’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameHemgenix
Authorized genericetranacogene dezaparvovec
Regular genericetranacogene dezaparvovec
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Hemgenix?
The original
–
–

Brand nameThe maker’s card

HEMGENIX Copay Support Program (HEMGENIX Connect)

Savings card from CSL Behring

No insuranceNeeds insuranceNo cash price listed.
Insurance $0

Sign up on hemgenix.com 

Or call 1-833-436-0021. See the offer on hemgenix.com

In the maker’s words

“$0 out-of-pocket cost for most commercially insured people…”

From the maker’s offer on hemgenix.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Hemgenix itself, from the same company, sold without the brand name, and usually for less. For now Hemgenix is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Hemgenix is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

HEMGENIX is an adeno-associated virus vector-based gene therapy indicated for the treatment of adults with Hemophilia B (congenital Factor IX deficiency) who:

  • Currently use Factor IX prophylaxis therapy, or
  • Have current or historical life-threatening hemorrhage, or
  • Have repeated, serious spontaneous bleeding episodes.

Source: the FDA label for Hemgenix (CSL Behring), May 1, 2026. Full label on DailyMed 

Good to know